3 A retrospective audit of mineralocorticoid receptor antagonist (mra) and device therapy following myocardial infarction (mi) complicated by left ventricular (lv) systolic dysfunction
3 A retrospective audit of mineralocorticoid receptor antagonist (mra) and device therapy following myocardial infarction (mi) complicated by left ventricular (lv) systolic dysfunction